1. Home
  2. MDXH vs NOTE Comparison

MDXH vs NOTE Comparison

Compare MDXH & NOTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • NOTE
  • Stock Information
  • Founded
  • MDXH 2003
  • NOTE 2013
  • Country
  • MDXH Belgium
  • NOTE United States
  • Employees
  • MDXH N/A
  • NOTE N/A
  • Industry
  • MDXH
  • NOTE EDP Services
  • Sector
  • MDXH
  • NOTE Technology
  • Exchange
  • MDXH Nasdaq
  • NOTE Nasdaq
  • Market Cap
  • MDXH 84.6M
  • NOTE 97.9M
  • IPO Year
  • MDXH 2021
  • NOTE N/A
  • Fundamental
  • Price
  • MDXH $2.00
  • NOTE $0.51
  • Analyst Decision
  • MDXH Buy
  • NOTE Strong Buy
  • Analyst Count
  • MDXH 1
  • NOTE 6
  • Target Price
  • MDXH $6.00
  • NOTE $2.63
  • AVG Volume (30 Days)
  • MDXH 73.0K
  • NOTE 2.0M
  • Earning Date
  • MDXH 05-14-2025
  • NOTE 08-07-2025
  • Dividend Yield
  • MDXH N/A
  • NOTE N/A
  • EPS Growth
  • MDXH N/A
  • NOTE N/A
  • EPS
  • MDXH N/A
  • NOTE N/A
  • Revenue
  • MDXH $94,507,000.00
  • NOTE $115,665,000.00
  • Revenue This Year
  • MDXH $23.50
  • NOTE N/A
  • Revenue Next Year
  • MDXH $17.30
  • NOTE $41.14
  • P/E Ratio
  • MDXH N/A
  • NOTE N/A
  • Revenue Growth
  • MDXH 25.46
  • NOTE N/A
  • 52 Week Low
  • MDXH $1.35
  • NOTE $0.48
  • 52 Week High
  • MDXH $3.50
  • NOTE $2.07
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 48.51
  • NOTE 34.03
  • Support Level
  • MDXH $2.07
  • NOTE $0.50
  • Resistance Level
  • MDXH $2.21
  • NOTE $0.65
  • Average True Range (ATR)
  • MDXH 0.12
  • NOTE 0.05
  • MACD
  • MDXH -0.02
  • NOTE -0.01
  • Stochastic Oscillator
  • MDXH 11.76
  • NOTE 15.41

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

About NOTE FiscalNote Holdings Inc.

FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.

Share on Social Networks: